Physician
Valley Pediatric Health
Valley Pediatric Health was paid $13.13M by Medicaid between Jan 2018 and Dec 2024, across 96 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 21% of everything it billed.
33Billing provider infoVALLEY PEDIATRIC HEALTH
EL CENTRO, CA 92243
EL CENTRO, CA 92243
33aNPI1598139883assigned 11/24/2015
33bProvider typePediatrics Physician
28Total paid$13.13M
24GClaims406,087
24DCodes billed96
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in California
Rank by total paid#13 of 1,490
Median peer was paid$15K
This provider vs. median876×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 37,663 | $1.06M | |
| 2019 | 49,619 | $1.44M | |
| 2020 | 48,948 | $1.39M | |
| 2021 | 64,385 | $2.55M | |
| 2022 | 82,915 | $2.87M | |
| 2023 | 82,921 | $2.51M | |
| 2024incomplete | 39,636 | $1.31M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 21% | 63,126 | 44,317 | $2.74M |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 13% | 24,489 | 22,325 | $1.72M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.9% | 15,426 | 14,595 | $911K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.2% | 12,191 | 10,692 | $810K |
| 97802 | 5.7% | 24,824 | 24,636 | $744K | |
| G9920 | Screening performed and negative | 3.1% | 14,541 | 13,449 | $411K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.1% | 6,006 | 5,970 | $411K |
| 90670 | 3.0% | 11,111 | 9,956 | $394K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.7% | 6,098 | 5,680 | $353K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 2.6% | 8,611 | 7,861 | $347K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.3% | 2,169 | 2,081 | $299K |
| 92552 | 1.9% | 13,938 | 13,817 | $244K |
84 more codes
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.8% | 13,933 | $231K |
| 99222 | Initial hospital care, per day, moderate complexity | 1.7% | 3,844 | $225K |
| 99188 | 1.5% | 10,459 | $192K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.3% | 531 | $176K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.3% | 2,094 | $167K |
| 90723 | 1.2% | 9,298 | $163K | |
| 90716 | 1.2% | 5,132 | $155K | |
| 90680 | 1.1% | 8,617 | $150K | |
| 99232 | Hospital visit by a doctor, follow-up day | 1.1% | 4,164 | $143K |
| 90648 | <1% | 11,784 | $129K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 4,947 | $127K |
| 90707 | <1% | 5,054 | $122K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 4,179 | $122K |
| 83655 | <1% | 10,875 | $118K | |
| 90686 | <1% | 9,613 | $112K | |
| 99460 | <1% | 2,547 | $95K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,220 | $94K |
| 90633 | <1% | 5,860 | $86K | |
| 99477 | <1% | 387 | $78K | |
| 90651 | <1% | 1,400 | $75K | |
| 92081 | <1% | 2,197 | $72K | |
| 90700 | <1% | 4,751 | $64K | |
| 86580 | <1% | 15,826 | $57K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 970 | $55K |
| 90733 | <1% | 420 | $50K | |
| 90480 | <1% | 1,134 | $44K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,170 | $42K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,323 | $41K |
| 99383 | <1% | 416 | $37K | |
| 99173 | <1% | 8,714 | $34K | |
| 90713 | <1% | 2,187 | $31K | |
| 85018 | <1% | 13,802 | $30K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,999 | $26K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,440 | $23K |
| 0081A | <1% | 567 | $23K | |
| 90677 | <1% | 633 | $22K | |
| 0071A | <1% | 516 | $20K | |
| 0082A | <1% | 496 | $20K | |
| 99382 | <1% | 223 | $20K | |
| 0072A | <1% | 478 | $19K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 248 | $18K |
| 88720 | <1% | 4,364 | $18K | |
| 85014 | <1% | 7,279 | $15K | |
| 0173A | <1% | 343 | $14K | |
| 0154A | <1% | 325 | $13K | |
| 90461 | <1% | 483 | $13K | |
| 87807 | <1% | 1,428 | $12K | |
| 90715 | <1% | 733 | $12K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 873 | $12K |
| 90657 | <1% | 1,002 | $9K | |
| 0001A | <1% | 214 | $8K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 227 | $8K |
| 0002A | <1% | 189 | $8K | |
| 0124A | <1% | 176 | $7K | |
| 0083A | <1% | 164 | $7K | |
| 90734 | <1% | 161 | $6K | |
| 90620 | <1% | 136 | $6K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 170 | $6K |
| 99384 | <1% | 60 | $6K | |
| 99462 | <1% | 238 | $6K | |
| 90381 | <1% | 116 | $6K | |
| 0073A | <1% | 135 | $5K | |
| A7016 | Dome and mouthpiece, used with small volume ultrasonic nebulizer | <1% | 787 | $5K |
| 87428 | <1% | 66 | $5K | |
| 90649 | <1% | 149 | $4K | |
| G9919 | Screening performed and positive and provision of recommendations | <1% | 83 | $2K |
| 99223 | Prolong inpt eval add15 m | <1% | 27 | $2K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 173 | $2K |
| 0003A | <1% | 54 | $2K | |
| S9451 | Exercise classes, non-physician provider, per session | <1% | 746 | $2K |
| 90380 | <1% | 148 | $2K | |
| 81003 | <1% | 960 | $2K | |
| 94760 | <1% | 1,608 | $2K | |
| 90658 | <1% | 136 | $2K | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 40 | $1K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 175 | $1K |
| 86403 | <1% | 123 | $1K | |
| 0004A | <1% | 30 | $1K | |
| 91318 | <1% | 504 | $917.51 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 49 | $363.61 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 2,034 | $281.51 |
| 91320 | <1% | 49 | $262.20 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 124 | $232.02 |
| 91319 | 0% | 228 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialALSHAREEF, AMEEN (MD)